Early diabetes signs often missed in those with Alzheimer’s, researcher says
By
Ashley Carman
Jul 16, 2013
A Georgetown University neurologist “was shocked” to find 48% of his study enrollees showed signs of undiagnosed prediabetes and diabetes.
Coming soon: a Breathalyzer for diabetes?
Jun 12, 2013
University of Pittsburgh researchers are developing a Breathalyzer than can detect and possibly monitor diabetes.
FDA panel gives diabetes drug Avandia a limited victory
Jun 12, 2013
A Food and Drug Administration advisory panel has voted to ease measures that limit patient access to the diabetes pill Avandia.
Avandia gets FDA win, but is unlikely to dominate market again
By
Elizabeth Newman
Jun 10, 2013
A Food and Drug Administration advisory panel has voted to ease measures that limit patient access to the diabetes pill Avandia. Many panelists, however, said precautions are still needed.
Five-day COPD treatment quells flare-ups, reduces side effects, researchers find
By
McKnight's Staff
May 23, 2013
Patients with chronic obstructive pulmonary disease flare-ups do better with a shorter round of prednisone, researchers have found.
Investigators find wound healing ‘switch’
By
John O'Connor
May 01, 2013
Researchers recently identified a molecular “switch” mechanism that takes place during successful wound care healing. The discovery is likely to aid in the understanding of how wounds get better,...
Early dementia, diabetes linked
By
McKnight's Staff
May 01, 2013
Diabetics are at risk of developing dementia earlier and dying sooner, according to research in the American Journal of Epidemiology.
Elderly left off diabetes trials
Apr 17, 2013
Far too few clinical trials are focused on seniors with diabetes, according to an analysis recently published in the journal Diabetologia. Researchers at the Duke University School of Medicine looked at...
Diabetics develop dementia 2 years sooner than others, researchers find
By
McKnight's Staff
Apr 15, 2013
People with diabetes are at risk of developing dementia earlier and dying sooner, according to recently published research.
New kind of diabetes drug gets OK
Apr 10, 2013
The Food and Drug Administration recently approved a new kind of type 2 diabetes drug to help better control glucose levels. Invokana prevents the kidney from reabsorbing glucose, according to the FDA.